NEW YORK (GenomeWeb News) – Roche Molecular Diagnostics this week said that its new Cobas p 630 Instrument has been launched with a CE Mark in Europe. The instrument is an automated, pre-analytical solution that is used with the firm's Amplilink 3.3 Series Software, which integrates the cobas p 630 with Roche's Cobas AmpliPrep Instruments and Cobas TaqMan Analyzers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.